デフォルト表紙
市場調査レポート
商品コード
1790213

電気生理学マッピングとアブレーションデバイスの市場規模、シェア、動向分析レポート:手技タイプ別、製品範囲別、地域別、セグメント別予測、2025年~2033年

Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type, By Product Coverage, By Region, And Segment Forecasts, 2025 - 2033


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
電気生理学マッピングとアブレーションデバイスの市場規模、シェア、動向分析レポート:手技タイプ別、製品範囲別、地域別、セグメント別予測、2025年~2033年
出版日: 2025年07月24日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

電気生理学マッピングとアブレーションデバイス市場概要

電気生理学マッピングとアブレーションデバイスの世界市場規模は、2024年に257億2,000万米ドルと推定され、2033年には626億1,000万米ドルに達すると予測され、2025~2033年のCAGRは9.23%で成長すると予測されます。複雑な不整脈、特に心房細動の診断と治療のための電気生理学マッピングとアブレーション機器の採用拡大が市場成長の主要促進要因です。

病院と外来の両方で先進的リズム管理ツールに対する需要が高まっていることに加え、座りがちなライフスタイル、喫煙、アルコール使用による若年層の心臓疾患負担が増加していることが、機器の利用を加速しています。ジョンソン・エンド・ジョンソンサービス社の2024年2月の記事によると、世界で3,750万人以上が心房細動に罹患しています。40歳以上の成人のおよそ4人に1人が、生涯のうちに心房細動を発症すると予測されています。複雑な不整脈、特に心房細動の診断と治療のために電気生理学的マッピングとアブレーションデバイスの使用が増加していることが、マーケットの主要な成長促進要因です。これらのデバイスは異常な電気経路を高精度に特定できるため、治療成績が向上し、再発率が低下します。臨床ガイドラインが症候性心房細動に対する最前線の治療法としてカテーテルアブレーションを強調し続けているため、世界中の大規模施設と新興のEPプログラムの両方で採用の機運が高まっています。2025年3月、アボット社は欧州のでVoltパルスフィールドアブレーション(PFA)システムのCEマーク承認を取得し、心房細動治療への商用利用が可能になりました。このシステムは、アボット社のEnSite Xマッピングプラットフォームと統合され、マッピング、ペーシング、アブレーションを1本のカテーテルで行い、ワークフローを簡略化するように設計されています。

病院と外来医療環境の両方における低侵襲心臓処置へのシフトは、先進的EPマッピングとアブレーションツールの需要を促進しています。これらの機器はリアルタイム画像と高解像度データを提供し、リズム管理ワークフローに不可欠なものとなりつつあります。2025年5月、EP EuropaceのEHRA-HRS-ESC合同コンセンサスは、AIベース電気生理学研究における標準化の改善を促しました。EHRAのAIチェックリストによると、必要不可欠な方法を報告している研究は55%以下であり、検査登録とモデルトレーニングの透明性は20%以下でした。この声明は、今後のAIの応用を、より臨床的な信頼性と再現性を高める方向に導くことを目的としています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の電気生理学マッピングとアブレーションデバイス市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 世界電気生理学マッピングとアブレーションデバイス:市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析
  • 技術
  • 使用事例分析

第4章 世界の電気生理学マッピングとアブレーションデバイス市場セグメント分析、手技タイプ別、2021~2033年

  • 定義と範囲
  • 手技タイプの市場シェア分析、2024年と2033年
  • セグメントダッシュボード
  • 世界の電気生理学マッピングとアブレーションデバイス市場、手技タイプ別、2021~2033年
  • EPアブレーション手順
    • 市場推定・予測2021~2033年
    • 適応症別
    • 心房細動
    • 右心房粗動
    • 左心房粗動
    • 房室結節リエントリー性頻拍(AVNRT)
    • 右心房頻拍(AT)
    • 左心房頻拍(AT)
    • 右ウォルフ・パーキンソン・ホワイト症候群(WPW)
    • 左ウォルフ・パーキンソン・ホワイト症候群(WPW)
    • 右室頻拍(VT)
    • 左室頻拍(VT)
    • 製品タイプ
  • スタンドアロンEP診断手順
    • 市場推定・予測2021~2033年

第5章 世界の電気生理学マッピングとアブレーションデバイス市場セグメント分析、製品範囲別、2021~2033年

  • 定義と範囲
  • 製品範囲市場シェア分析、2024年と2033年
  • セグメントダッシュボード
  • 世界の電気生理学マッピングとアブレーションデバイス市場、製品範囲別、2021~2033年
  • マッピングとラボシステム
    • 市場推定・予測2021~2033年
    • X線システム
    • マッピングシステム
    • EPレコーディングシステム
    • ICEシステム
    • RFアブレーションジェネレータ
    • パルスフィールドアブレーションジェネレータ
    • クライオアブレーションジェネレータ
  • 診断用カテーテル
    • 市場推定・予測2021~2033年
    • 従来型
    • 先進型
    • 超音波
  • アブレーションカテーテル
    • 市場推定・予測2021~2033年
    • 局所アブレーションカテーテル
    • バルーンアブレーションカテーテル
  • アクセサリデバイス
    • 市場推定・予測2021~2033年
    • ロングイントロデューサーシース
    • 経中隔針
    • ナビゲーションアクセサリ

第6章 電気生理学マッピングとアブレーションデバイス市場セグメント分析、地域別、2021~2033年

  • 地域別市場シェア分析、2024年と2034年
  • 地域別市場ダッシュボード
  • 地域市場のスナップショット
  • 電気生理学マッピングとアブレーション機器市場シェア(地域別)、2024年と2033年
  • 北米
    • 北米の電気生理学マッピングとアブレーションデバイス市場、2021~2033年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の電気生理学マッピングとアブレーションデバイス市場、2021~2033年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Abbott
    • Johnson & Johnson(Biosense Webster)
    • GE HealthCare
    • Boston Scientific Corporation
    • Medtronic
    • BIoTronik SE & Co KG
    • MicroPort Scientific Corporation
    • CardioFocus, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table3 Global electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 4 Global electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 5 Global electrophysiology (EP) mapping and ablation devices market, by region, 2021 - 2033 (USD Million)
  • Table 6 North America electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America electrophysiology (EP) mapping and ablation devices market, by procedure type 2021 - 2033 (USD Thousand)
  • Table 8 North America electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 9 U.S. electrophysiology (EP) mapping and ablation devices market, by procedure type 2021 - 2033 (USD Thousand)
  • Table 10 U.S. electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 11 Canada electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 12 Canada electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 13 Mexico electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 14 Mexico electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 15 Europe electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 17 Europe electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 18 UK electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 19 UK electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 20 Germany electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 21 Germany electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 22 France electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 23 France electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 24 Italy electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 25 Italy electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 26 Spain electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 27 Spain electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 28 Denmark electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 29 Denmark electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 30 Sweden electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 31 Sweden electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 32 Norway electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 33 Norway electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 36 Asia Pacific electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 37 Japan electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 38 Japan electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 39 China electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 40 China electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 41 India electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 42 India electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 43 Australia electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 44 Australia electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 45 Australia electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 46 Thailand electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 47 Thailand electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 48 South Korea electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 49 South Korea electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 50 Latin America electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 51 Latin America electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 52 Latin America electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 53 Brazil electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 54 Brazil electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 55 Argentina electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 56 Argentina electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 57 MEA electrophysiology (EP) mapping and ablation devices market, by country, 2021 - 2033 (USD Million)
  • Table 58 MEA electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 59 MEA electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 60 South Africa electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 61 South Africa electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 63 Saudi Arabia electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 64 UAE electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 65 UAE electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)
  • Table 66 Kuwait electrophysiology (EP) mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Thousand)
  • Table 67 Kuwait electrophysiology (EP) mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global electrophysiology (EP) mapping and ablation devices market: outlook
  • Fig. 9 Global electrophysiology (EP) mapping and ablation devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 Global electrophysiology (EP) mapping and ablation devices market driver impact
  • Fig. 13 Global electrophysiology (EP) mapping and ablation devices market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Global electrophysiology (EP) mapping and ablation devices market: Procedure type movement analysis
  • Fig. 17 Global electrophysiology (EP) mapping and ablation devices market: Procedure type outlook and key takeaways
  • Fig. 18 Global EP ablation procedures market, 2021 - 2033 (USD Thousand)
  • Fig. 19 Global atrial fibrillation market, 2021 - 2033 (USD Thousand)
  • Fig. 20 Global paroxysmal AF market, 2021 - 2033 (USD Thousand)
  • Fig. 21 Global persistent AF market, 2021 - 2033 (USD Thousand)
  • Fig. 22 Global long standing persistent/permanent market, 2021 - 2033 (USD Thousand)
  • Fig. 23 Global right atrial flutter market, 2021 - 2033 (USD Thousand)
  • Fig. 24 Global left atrial flutter market, 2021 - 2033 (USD Thousand)
  • Fig. 25 Global atrioventricular nodal reentry tachycardia (AVNRT) market, 2021 - 2033 (USD Thousand)
  • Fig. 26 Global left atrial tachycardia (AT) market, 2021 - 2033 (USD Thousand)
  • Fig. 27 Global right atrial tachycardia (AT) market, 2021 - 2033 (USD Thousand)
  • Fig. 28 Global right wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Thousand)
  • Fig. 29 Global left wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Thousand)
  • Fig. 30 Global right ventricular tachycardia (VT) market, 2021 - 2033 (USD Thousand)
  • Fig. 31 Global left ventricular tachycardia (VT) market, 2021 - 2033 (USD Thousand)
  • Fig. 32 Global focal ablation catheter market, 2021 - 2033 (USD Thousand)
  • Fig. 33 Global radiofrequency (RF) market, 2021 - 2033 (USD Thousand)
  • Fig. 34 Global conventional market, 2021 - 2033 (USD Thousand)
  • Fig. 35 Global irrigated-tip market, 2021 - 2033 (USD Thousand)
  • Fig. 36 Global contact-force-sensing market, 2021 - 2033 (USD Thousand)
  • Fig. 37 Global standard market, 2021 - 2033 (USD Thousand)
  • Fig. 38 Global alternative energy market, 2021 - 2033 (USD Thousand)
  • Fig. 39 Global pulsed field ablation market, 2021 - 2033 (USD Thousand)
  • Fig. 40 Global balloon ablation catheters market, 2021 - 2033 (USD Thousand)
  • Fig. 41 Global electrophysiology (EP) mapping and ablation devices market: Product coverage movement analysis
  • Fig. 42 Global electrophysiology (EP) mapping and ablation devices market: Product coverage outlook and key takeaways
  • Fig. 43 Global mapping & lab systems market, 2021 - 2033 (USD Million)
  • Fig. 44 Global x-ray systems market, 2021 - 2033 (USD Million)
  • Fig. 45 Global mapping systems market, 2021 - 2033 (USD Million)
  • Fig. 46 Global EP recording systems market, 2021 - 2033 (USD Million)
  • Fig. 47 Global ICE systems market, 2021 - 2033 (USD Million)
  • Fig. 48 Global RF ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 49 Global pulsed field ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 50 Global cryoablation generators market, 2021 - 2033 (USD Million)
  • Fig. 51 Global diagnostic catheters market, 2021 - 2033 (USD Million)
  • Fig. 52 Global conventional market, 2021 - 2033 (USD Million)
  • Fig. 53 Global fixed market, 2021 - 2033 (USD Million)
  • Fig. 54 Global steerable market, 2021 - 2033 (USD Million)
  • Fig. 55 Global advanced market, 2021 - 2033 (USD Million)
  • Fig. 56 Global ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 57 Global ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 58 Global focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 59 Global radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 60 Global conventional market, 2021 - 2033 (USD Million)
  • Fig. 61 Global irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 62 Global contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 63 Global standard market, 2021 - 2033 (USD Million)
  • Fig. 64 Global alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 65 Global pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 66 Global balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 67 Global accessory devices market, 2021 - 2033 (USD Million)
  • Fig. 68 Global long introducer sheaths market, 2021 - 2033 (USD Million)
  • Fig. 69 Global fixed market, 2021 - 2033 (USD Million)
  • Fig. 70 Global steerable market, 2021 - 2033 (USD Million)
  • Fig. 71 Global transseptal needles market, 2021 - 2033 (USD Million)
  • Fig. 72 Global conventional market, 2021 - 2033 (USD Million)
  • Fig. 73 Global RF market, 2021 - 2033 (USD Million)
  • Fig. 74 Global navigational accessories market, 2021 - 2033 (USD Million)
  • Fig. 75 Global electrophysiology (EP) mapping and ablation devices market: Regional movement analysis
  • Fig. 76 Global electrophysiology (EP) mapping and ablation devices market: Regional outlook and key takeaways
  • Fig. 77 North America electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 U.S. electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Canada electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Mexico electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Europe electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 UK electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Germany electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Spain electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 France electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Italy electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Norway electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Denmark electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Sweden electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 101 Asia Pacific electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Japan electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 China electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 India electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Australia electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 South Korea electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Thailand electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Latin America electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Brazil electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Argentina electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 119 MEA electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 South Africa electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 122 Key country dynamics
  • Fig. 123 Saudi Arabia electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 UAE electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 126 Key country dynamics
  • Fig. 127 Kuwait electrophysiology (EP) mapping and ablation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 128 Key company categorization
  • Fig. 129 Heat map analysis 2024
目次
Product Code: GVR-4-68040-687-0

Electrophysiology Mapping And Ablation Devices Market Summary

The global electrophysiology mapping and ablation devices market size was estimated at USD 25.72 billion in 2024 and is projected to reach USD 62.61 billion by 2033, growing at a CAGR of 9.23% from 2025 to 2033. Growing adoption of electrophysiology (EP) mapping and ablation devices for the diagnosis and treatment of complex arrhythmias, particularly atrial fibrillation, is a key driver of market growth.

Rising demand for advanced rhythm management tools in both hospital and ambulatory settings, coupled with the increasing burden of cardiac conditions among younger populations due to sedentary lifestyles, smoking, and alcohol use, is accelerating device utilization. According to a February 2024 article by Johnson & Johnson Services, Inc., over 37.5 million people globally are affected by atrial fibrillation. Roughly 1 in 4 adults over 40 are projected to develop the condition during their lifetime. The increasing use of electrophysiology mapping and ablation devices for diagnosing and treating complex arrhythmias, especially atrial fibrillation, is a major growth catalyst for the market. These devices allow for highly precise localization of abnormal electrical pathways, improving procedural outcomes and reducing recurrence rates. As clinical guidelines continue to emphasize catheter ablation as a frontline therapy for symptomatic AF, adoption is gaining momentum among both high-volume centers and emerging EP programs worldwide. In March 2025, Abbott received CE Mark approval in Europe for its Volt Pulsed Field Ablation (PFA) System, enabling commercial use for atrial fibrillation treatment. The system integrates with Abbott's EnSite X mapping platform and is designed to simplify workflows using a single catheter for mapping, pacing, and ablation.

The shift toward minimally invasive cardiac procedures in both hospital and ambulatory care environments is driving demand for advanced EP mapping and ablation tools. These devices are becoming integral to rhythm management workflows, offering real-time imaging and high-resolution data. In May 2025, a joint EHRA-HRS-ESC consensus in EP Europace urged improved standardization in AI-based electrophysiology research. The EHRA AI checklist showed that fewer than 55% of studies reported essential methods, with transparency in trial registration and model training below 20%, highlighting the need for more rigorous reporting practices. The statement aims to guide future AI applications toward greater clinical reliability and reproducibility.

Global Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. for this study, Grand View Research has segmented the global electrophysiology mapping and ablation devices market report based on procedure type, product coverage, and region:

  • Procedure Type Outlook (Revenue, USD Thousand, 2021 - 2033)
  • EP Ablation Procedures
    • By Indication
    • Atrial Fibrillation
    • Paroxysmal AF
    • Persistent AF
    • Long standing persistent/permanent
    • Right Atrial Flutter
    • Left Atrial Flutter
    • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
    • Right Atrial Tachycardia (AT)
    • Left Atrial Tachycardia (AT)
    • Right Wolff-Parkinson-White (WPW
    • Left Wolff-Parkinson-White (WPW)
    • Right Ventricular Tachycardia (VT)
    • Left Ventricular Tachycardia (VT)
  • Stand-Alone EP Diagnostic Procedures
    • By Product Type
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
  • Mapping & Lab Systems
    • X-Ray Systems
    • Mapping Systems
    • EP Recording Systems
    • ICE Systems
    • RF Ablation Generators
    • Pulsed Field Ablation Generators
    • Cryoablation Generators
  • Diagnostic Catheters
    • Conventional
    • Fixed
    • Steerable
    • Advanced
    • Ultrasound
  • Ablation Catheters
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Accessory Devices
    • Long Introducer Sheaths
    • Fixed
    • Steerable
  • Transseptal Needles
    • Conventional
    • RF
  • Navigational Accessories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure type outlook
    • 2.2.2. Product coverage outlook
  • 2.3. Competitive Insights

Chapter 3. Global Electrophysiology (EP) Mapping and Ablation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Electrophysiology (EP) Mapping and Ablation Devices: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Technology Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Procedure Type Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Procedure Type, 2021 to 2033
  • 4.5. EP Ablation Procedures
    • 4.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.2. By Indication
    • 4.5.3. Atrial Fibrillation
      • 4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
      • 4.5.3.2. Paroxysmal AF
        • 4.5.3.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
      • 4.5.3.3. Persistent AF
        • 4.5.3.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
      • 4.5.3.4. Long standing persistent/permanent
        • 4.5.3.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.4. Right Atrial Flutter
      • 4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.5. Left Atrial Flutter
      • 4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
      • 4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.7. Right Atrial Tachycardia (AT)
      • 4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.8. Left Atrial Tachycardia (AT)
      • 4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.9. Right Wolff-Parkinson-White (WPW)
      • 4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.10. Left Wolff-Parkinson-White (WPW)
      • 4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.11. Right Ventricular Tachycardia (VT)
      • 4.5.11.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.12. Left Ventricular Tachycardia (VT)
      • 4.5.12.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
    • 4.5.13. By Product Type
      • 4.5.13.1. Focal ablation catheter
        • 4.5.13.1.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
        • 4.5.13.1.2. Radiofrequency (RF)
          • 4.5.13.1.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
          • 4.5.13.1.2.2. Conventional
            • 4.5.13.1.2.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
          • 4.5.13.1.2.3. Irrigated-tip
            • 4.5.13.1.2.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
            • 4.5.13.1.2.3.2. Contact-force-sensing
            • 4.5.13.1.2.3.3. Standard
        • 4.5.13.1.3. Alternative energy
          • 4.5.13.1.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
        • 4.5.13.1.4. Pulsed field ablation
          • 4.5.13.1.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
      • 4.5.13.2. Balloon ablation catheters
        • 4.5.13.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
  • 4.6. Stand-Alone EP Diagnostic Procedures
    • 4.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)

Chapter 5. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Product Coverage, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Product Coverage Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Product Coverage, 2021 to 2033
  • 5.5. Mapping & Lab Systems
    • 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.2. X-Ray Systems
      • 5.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.3. Mapping Systems
      • 5.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.4. EP Recording Systems
      • 5.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.5. ICE Systems
      • 5.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.6. RF Ablation Generators
      • 5.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.7. Pulsed Field Ablation Generators
      • 5.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.5.8. Cryoablation Generators
      • 5.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.6. Diagnostic Catheters
    • 5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.6.2. Conventional
      • 5.6.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.6.2.2. Fixed
        • 5.6.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.6.2.3. Steerable
        • 5.6.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.6.3. Advanced
      • 5.6.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.6.4. Ultrasound
      • 5.6.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.7. Ablation Catheters
    • 5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.7.2. Focal Ablation Catheter
      • 5.7.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.7.2.2. Radiofrequency (RF)
        • 5.7.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
        • 5.7.2.2.2. Conventional
          • 5.7.2.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
        • 5.7.2.2.3. Irrigated-tip
          • 5.7.2.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
          • 5.7.2.2.3.2. Contact-force-sensing
            • 5.7.2.2.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
          • 5.7.2.2.3.3. Standard
            • 5.7.2.2.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.7.2.3. Alternative energy
        • 5.7.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.7.2.4. Pulsed field ablation
        • 5.7.2.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.7.3. Balloon Ablation Catheters
      • 5.7.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.8. Accessory Devices
    • 5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.8.2. Long Introducer Sheaths
      • 5.8.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.8.2.2. Fixed
        • 5.8.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.8.2.3. Steerable
        • 5.8.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.8.3. Transseptal Needles
      • 5.8.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.8.3.2. Conventional
        • 5.8.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
      • 5.8.3.3. RF
        • 5.8.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 5.8.4. Navigational Accessories
      • 5.8.4.1. Market estimates and forecast 2021 - 2033 (USD Million)

Chapter 6. Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2034
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Electrophysiology (EP) Mapping and Ablation Devices Market Share by Region, 2024 & 2033
  • 6.5. North America
    • 6.5.1. North America electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Scenario
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Scenario
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Scenario
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Scenario
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Scenario
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Scenario
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Scenario
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Scenario
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Scenario
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Scenario
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Scenario
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Scenario
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Scenario
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Scenario
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Scenario
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Scenario
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Scenario
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Scenario
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Scenario
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Scenario
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Scenario
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Scenario
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Scenario
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Siemens Healthineers
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Koninklijke Philips N.V.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Abbott
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Johnson & Johnson (Biosense Webster)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. GE HealthCare
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Medtronic
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Biotronik SE & Co KG
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. MicroPort Scientific Corporation
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. CardioFocus, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives